UNSPSC 51262304: Pirepolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C21H32N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V1J0B4P41O, chemically known as (+-)-6-((2-((3-(p-butoxyphenoxy)-2-hydroxypropyl)amino)ethyl)amino)-1,3-dimethyluracil but generally known as pirepolol, which bears US NIH Compound Identifier 68887. European Medicines Agency schedules Pirepolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09905MIG.

UNSPSC 51262304 Pirepolol is a Commodity code tracking pharmaceutical products, specifically naloxone and drug deactivation systems, that state and local governments procure to support community health and emergency response initiatives. State and local issuing bodies under this code include county health departments and state health and human services agencies. Naloxone procurement dominates recent activity, with governments buying the opioid antagonist in bulk quantities for distribution through community health programs and emergency response networks. The work involves standardized product sourcing with defined delivery schedules and inventory management rather than specialized manufacturing or formulation work.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the bid deadline was July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities and market intelligence regarding direct-to-manufacturer prescription programs, signaling potential expansion of state-level pharmaceutical procurement models beyond traditional pharmacy benefit manager channels. Recent activity spans Florida and Texas, with the Texas inquiry suggesting broader state-level interest in alternative distribution models for pharmaceutical products. The Seminole County opportunity required E-Verify compliance, drug-free workplace certification, and specific insurance coverage; contracts carried two-year initial terms with one-year renewal options and included three-month probationary termination rights.